AstraZeneca Pharma India declined 1.57% to Rs 9,878 after the company said its managing director (MD), Sanjeev Kumar Panchal has resigned from his position with effect from the close of business on 30 ...

Bangalore: AstraZeneca Pharma India has announced the appointment of Praveen Rao Akkinepally as the new Managing Director of ...

AstraZeneca’s top business, oncology, increased 10% (up 13% ... It also has two large R&D sites in Gaithersburg MD and Cambridge MA.” Guidance: For fiscal year 2025, AstraZeneca forecasts ...

In Q1 2025, total revenue jumped 10 per cent to $13.5bn, driven by double-digit growth in Oncology and BioPharmaceuticals The ... leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA ...

Pascal Soriot, Chief Executive Officer, AstraZeneca, said ... leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA. Overall, we are making excellent progress toward our ambition ...

Additionally, we have even greater US investment in manufacturing and R&D planned, leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA. Overall, we are making excellent progress ...

Additionally, we have even greater US investment in manufacturing and R&D planned, leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA ... the eleven US manufacturing sites.

Pascal Soriot, Chief Executive Officer, AstraZeneca, said: "Our strong growth momentum ... leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA. Overall, we are making excellent ...

Click on, or paste, the following link into your web browser, to view the associated PDF document. http://www.rns-pdf.londonstockexchange.com/rns/5152G_1-2025-4-28 ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Tempus AI said it will work with AstraZeneca and ...

This agreement builds upon a previous partnership with AstraZeneca established in 2021, with the goal of advancing therapeutic programs in oncology on a global scale through Tempus’ AI-enabled ...